The slow loss of memory, thinking, and independence that defines Alzheimer’s disease continues to affect millions worldwide.

A baby known as KJ is the first person in the world to receive a customized CRISPR therapy designed to fix a specific ...

Lafora disease is a rare, fatal genetic disorder affecting the brain, with limited treatment options and severe symptoms.

Netherlands biotech Azafaros is poised to start phase 3 trials of its lead drug for a trio of rare lysosomal storage ...

Pharma major Lupin Ltd on Tuesday said it has launched the Tolvaptan tablets used to slow kidney function decline in the US ...

Lupin has launched generic Tolvaptan tablets for kidney disorder treatment in the US, providing increased access to ...